Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rahko logo — Part of Odyssey Therapeutics

Rahko

Part of Odyssey Therapeutics

Founded 2018 United Kingdom London, United Kingdom 1 employees Seed Total: $1.30M Hardware, IT +1

General Information

Company Name Rahko
Founded Year 2018
Location United Kingdom London, United Kingdom
Employees 1
Industries Hardware, IT, Machine Learning
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Rahko. To contact Rahko, visit rahko.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Rahko

Rahko, acquired by Odyssey Therapeutics in 2021, is a startup operating under the umbrella of Odyssey Therapeutics, a pioneering biotech company focusing on next-gen immunomodulators and oncology medicine. Established in 2018 and headquartered in the United Kingdom, Rahko operates in the industries of hardware, IT, and machine learning. The company secured a notable £1.30M in a Seed Round investment on 11 October 2019, with backing from high-profile investors including Balderton Capital, TGM Ventures, AI Seed, John Spindler, James Field, Charlie Songhurst, and Thomas McInerney. For more information, visit Odyssey Therapeutics.

Taxonomy: biotech, immunomodulators, oncology medicine, quantum machine learning, quantum software, quantum hardware engineering, quantum chemistry, chemical simulation, partnership, commercially valuable problems

Services & Products

Domain Name Sales and Acquisition

Target Customers

Individuals and Businesses looking to buy or lease domain names

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £1.30M 7
Balderton Capital TGM ventures AI Seed
Balderton Capital, TGM ventures +5
11 Oct 2019

Latest News

View All
Conception X launches angel syndicate for Europe’s deeptech PhDs — Tech
Conception X launches angel syndicate for Europe’s deeptech PhDs
Tech May 13, 2025

Rahko Alternatives & Competitors

Rahko vs
Lenovo
Lenovo United States

Smarter technology for all

Convertible Note
47426 employees
Hardware, IT

FAQ About Rahko

Part of Odyssey Therapeutics
Rahko was founded in 2018.
Rahko is headquartered in London, United Kingdom.
Rahko operates in Hardware, IT and Machine Learning. Its work centres on biotech, immunomodulators, oncology medicine and quantum machine learning. Its customers include Individuals and Businesses looking to buy or lease domain names.
Rahko has approximately 1 employees.
Rahko has completed 1 funding round, raising a total of $1.30M. The latest funding stage is Seed.
Rahko offers: Domain Name Sales and Acquisition.
Top alternatives and competitors to Rahko include Lenovo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rahko and Lenovo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rahko, https://bouncewatch.com/company/rahko, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes